Outcome Of Childhood Asthma In Adult Life And The Interaction With COPD
Funder
National Health and Medical Research Council
Funding Amount
$503,549.00
Summary
The Melbourne Study of Childhood Asthma (MESCA) is the longest, most comprehensive follow-up study of childhood asthma. The members were recruited in 1964 at the age of 7 and they have been reviewed at ages 10, 14, 21, 28, 35 and 42 years of age with a retention rate of 87% of survivors at the most recent follow-up. To date, the MESCA study has provided comprehensive data on the outcome of childhood asthma through to their adult years and has been particularly influential in establishing approac ....The Melbourne Study of Childhood Asthma (MESCA) is the longest, most comprehensive follow-up study of childhood asthma. The members were recruited in 1964 at the age of 7 and they have been reviewed at ages 10, 14, 21, 28, 35 and 42 years of age with a retention rate of 87% of survivors at the most recent follow-up. To date, the MESCA study has provided comprehensive data on the outcome of childhood asthma through to their adult years and has been particularly influential in establishing approaches to treatment of paediatric asthma nationally and internationally. The results of the study have been published widely over the years and cited extensively. The members of this cohort turn 50 in 2007 and will be invited to participate in a further review to reassess their clinical outcome to examine the relationship between long standing asthma and the development of COPD. Those members of the cohort who have had asthma persisting through their adult years have a degree of fixed obstruction on their tests of lung function and are potentially at risk of developing COPD. Some are at increased risk as approximately 30% of the members are regular smokers. In this review, at age 59 years, there is an excellent opportunity to examine the interaction of asthma and COPD and to compare the inflammatory processes between those who have continuing asthma, those whose asthma has resolved and in each group examine the effect of smoking. We will also look at a numbers of genetic markers associated with COPD to identify those who are more susceptible to the development of COPD. A second area of interest is the components of the immune system that influence asthma.. In an earlier study we identified one component of the immune system, known as the T cell system, that had returned to normal in those whose asthma had resolved. In this review, we plan to examine the T cell system in detail to understand what mechanisms may be responsible for resolution of childhood asthma.Read moreRead less
Optimising Asthma Management In Pregnancy For Optimal Infant Health
Funder
National Health and Medical Research Council
Funding Amount
$428,065.00
Summary
Asthma affects 12% of pregnant women in Australia. These women are at increased risk of poor pregnancy outcomes, such as preterm birth and hospitalisation of the neonate. Reducing asthma attacks by providing optimal asthma management during pregnancy may lower these risks. This research will test whether a strategy which determines treatment changes based on a marker of airway inflammation, improves outcomes for maternal, neonatal and child health.
Improving Outcomes In Pregnancies Complicated By Asthma: Understanding Mechanisms And Defining Interventions
Funder
National Health and Medical Research Council
Funding Amount
$707,370.00
Summary
Asthma is a common disease to complicate pregnancy and it is important to identify ways of effectively managing the disease to ensure the fetus has the best possible outcome. The current research focusses on this disease and looks at ways of improving management in pregnancy and improving outcomes for the baby.
Asthma Management In Pregnancy: Evaluating Costs, Benefits And Behaviours
Funder
National Health and Medical Research Council
Funding Amount
$319,157.00
Summary
Asthma is the most common complication to affect pregnancy and it worsens with pregnancy contributing to an increased incidence of morbidity and mortality for the baby. We think we can improve the health of the pregnant, asthmatic mothers and prevent a poor outcome for the baby by empowering asthmatic mothers to self manage their disease through education in an antenatal setting. We will assess whether antenatal asthma education and management is a cost effective approach to managing this diseas ....Asthma is the most common complication to affect pregnancy and it worsens with pregnancy contributing to an increased incidence of morbidity and mortality for the baby. We think we can improve the health of the pregnant, asthmatic mothers and prevent a poor outcome for the baby by empowering asthmatic mothers to self manage their disease through education in an antenatal setting. We will assess whether antenatal asthma education and management is a cost effective approach to managing this disease during pregnancy.Read moreRead less
Infant Risk Factors For Childhood Asthma And Academic Performance
Funder
National Health and Medical Research Council
Funding Amount
$40,492.00
Summary
This research aims to determine whether factors affecting the foetus or the infant have long term consequences on health. The aspects of health I am focusing on are respiratory health- asthma and lung function, and cognitive performance. The perinatal and infant factors I am using in analysis are birth measures such as weight and length, breast feeding duration, and pro-longed supplementation with omega-3 fatty acids.
This project will take robust evidence regarding inflammation based management, comorbidity and self management and translate it into practice using a national implementation framework.
Age-related Macular Degeneration: A Cause And A Cure
Funder
National Health and Medical Research Council
Funding Amount
$828,300.00
Summary
Age-related macular degeneration (AMD) is a leading cause of vision loss and there is urgent need for an intervention to slow disease progression. AMD is characterised by debris accumulation in the retina and I will investigate if loss of function in cells that should clear this debris is a critical step in the development of AMD. I will trial a novel laser intervention to slow progression of disease and use basic science techniques to investigate the mechanisms of action of the laser.